Synvichor* is the world’s first genomic PCR test that sets a new medical standard globally for the rapid, accurate and reliable differentiation of joint pain.

*Synvichor is not approved by the TGA. Synvichor is for Research Use only. Not for use in diagnostic procedures.

Undifferentiated joint pain: a global problem

When a patient presents with a red, hot, swollen and painful joint, reliably differentiating infection from inflammation poses a significant global problem.

Typical wait times for culture results vary from 24hrs to 21 days, with a true positivity of up to 20%, meaning they are inconclusive more than 80% of the time.

Rather than risk missing or misdiagnosing an infection, the current approach sees the patient admitted to hospital and treated with antibiotics.

This results in uncertainty for patients and clinicians, increased costs to the hospital, and poorer outcomes.

Unparalleled speed, precision, and reliability

With up to 95% negative and positive predictive value and results in ~3 hours, Synvichor* provides rapid and reliable differentiation of joint pain.

Synvichor* helps to rapidly assess which patients require urgent treatment for infection, and which patients can be safely managed in the community for non-infectious inflammation.

*For Research Use only. Not for use in diagnostic procedures.
Synvichor Logo
  • Enhances your diagnostic speed
  • Optimises your treatment options
  • Enables clinicians to safely manage up to two-thirds of patients in the community


Synvichor Logo

~3 hours

vs. current culture testing

24 hours – 21 days

Group 4218


Synvichor Logo


vs. current culture testing

13-20% accuracy1

1. Graue C et al. Open Forum Infect Dis. 2020; 7(Suppl 1):S233–4. *For Research Use only. Not for use in diagnostic procedures.

Our products

A solution for every joint type, every time

Synvichor has been designed to fit into your existing testing and work-up routine for all patients with undifferentiated joint pain.

Simple Order

for native joints

Native Logo
Packaging Native

For prosthetic joints

Prosthetic Logo
Packaging Prosthetic

Innovation that improves outcomes

Synvichor sets a new global medical standard that enhances surgeon’s treatment decisions, improves outcomes for patients, and reduces the burden on the hospital system.

See how

Synvichor has the potential to deliver billion-dollar savings to the healthcare system annually and significantly increase hospital bed day capacity per year

Contact us

Get in touch to find out how Synvichor can help you, your patients and your hospital.

Contact us

Be the first to know more as news breaks